HighGravityDataGilead Sciences — Apr 24, 2025 release
Fiscal 2025 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000882095-25-000009
Showing in the filing
GAAP projected product gross margin
“77.0% - 78.0%”
Period
FY2025
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 18
Product sales for FY2025
“$ 28,200” – “$ 28,600”
Product sales
“$ 28,200”
Product sales excluding Veklury for FY2025
“$ 26,800” – “$ 27,200”
Product sales excluding Veklury
“$ 26,800”
Veklury (High End) for FY2025
“$ 1,400”
Veklury
“$ 1,400”
Diluted EPS for FY2025
“$ 5.65” – “$ 6.05”
Diluted EPS
“$ 5.65”
Non-GAAP diluted EPS for FY2025
“$ 7.70” – “$ 8.10”
Non-GAAP diluted EPS
“$ 7.70”
Quarterly dividend declared for Q2 2025 for Q2 FY2025
“$0.79 per share of common stock”
Quarterly dividend of common stock for Q2 FY2025
“$0.79 per share”
GAAP projected product gross margin for FY2025
“77.0% - 78.0%”
Non-GAAP projected product gross margin for FY2025
“85.0% - 86.0%”
GAAP projected operating income for FY2025
“$10,200 - $10,700”
Non-GAAP projected operating income for FY2025
“$12,700 - $13,200”
GAAP projected effective tax rate for FY2025
“~ 21%”
Non-GAAP projected effective tax rate for FY2025
“~ 19%”
Exhibit 99.1 · the passage around this item
… earlier in the release
RECONCILIATION OF GAAP TO NON-GAAP 2025 FULL-YEAR GUIDANCE (1) (unaudited) (in millions, except percentages and per share amounts) Provided February 11, 2025 Updated April 24, 2025 Projected product gross margin GAAP to non-GAAP reconciliation: GAAP projected product gross margin 77.0% - 78.0% 77.0% - 78.0% Acquisition-related expenses ~ 8.0% ~ 8.0% Non-GAAP projected product gross margin 85.0% - 86.0% 85.0% - 86.0% Projected operating income GAAP to non-GAAP reconciliation: GAAP projected operating income $10,200 - $10,700 $10,200 - $10,700 Acquisition-related and restructuring expenses ~ 2,500 ~ 2,500 Non-GAAP projected operating income $12,700 - $13,200 $12,700 - $13,200 Projected effective tax rate GAAP to non-GAAP reconciliation: GAAP projected effective tax rate ~ 20% ~ 21% Income tax effect of above non-GAAP adjustments and fair value adjustments of equity securities, and discrete and related tax adjustments (~ 1%) (~ 2%) Non-GAAP projected effective tax rate ~ 19% ~ 19% Projected diluted EPS GAAP to non-GAAP reconciliation: GAAP projected diluted EPS $5.95 - $6.35 $5.65 - $6.05 Acquisition-related and restructuring expenses, fair value adjustments of equity securities and discrete and related tax adjustments ~ 1.75 ~ 2.05 Non-GAAP projected diluted EPS $7.70 - $8.10 $7.70 - $8.10 ________________________________ (1) Our full-year guidance excludes the potential impact of any (i) acquisitions or business development transactions that have not been executed, (
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.